Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

14.960
-0.400-2.60%
Volume:245.14K
Turnover:3.70M
Market Cap:5.07B
PE:112.56
High:15.300
Open:15.220
Low:14.940
Close:15.360
52wk High:18.320
52wk Low:8.260
Shares:338.72M
Float Shares:275.41M
Volume Ratio:1.68
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.133
EPS(LYR):-0.029
ROE:7.36%
ROA:2.71%
PB:7.46
PE(LYR):-508.84

Loading ...

3 Australian Growth Stocks Where Insider Ownership Could Matter Most

Simply Wall St.
·
Jul 26

Telix Stock And Other Fast Growing Insider Owned Shares Worth A Closer Look

Simply Wall St.
·
Jul 24

Telix Says Thyroid Cancer Therapy Candidate Shows Encouraging Disease Control, Acceptable Safety Profile in Real-World Data Review

MT Newswires Live
·
Jul 24

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.
·
Jul 23

3 Australian Growth Stocks Where Insider Ownership Signals Stronger Conviction

Simply Wall St.
·
Jul 22

U.S. Stocks on the Move-duke Robotics, Tesla, Hasbro

Reuters
·
Jul 22

U.S. Stocks on the Move-utz Brands, Tutor Perini, Tripadvisor

Reuters
·
Jul 21

Telix Pharmaceuticals Carries Meaningful Upside on Potential Product Approvals, Jefferies Says

MT Newswires Live
·
Jul 21

3 Australian Growth Stocks Trading Below Fair Value With Strong Insider Backing

Simply Wall St.
·
Jul 21

Australia's Telix Pharmaceuticals Gains on Upbeat Quarterly Revenue

Reuters
·
Jul 21

Telix Q2 Revenue Us$247m, Strong Momentum and Pipeline Progress

THOMSON REUTERS
·
Jul 21

Telix Appoints Three New Non-executive Directors to Expanded Board

Reuters
·
Jul 21

Telix Expects Fy2026 Revenue and Other Income Above US$1 Billion, Tracks Upper End of Guidance Range

Reuters
·
Jul 21

Telix Pharmaceuticals Ltd - Telix Expects FY 2026 Revenue and Other Income to be in Excess of US$1 Bln

THOMSON REUTERS
·
Jul 21

Telix Doses First Patient in Phase 3 Luteon Trial of Tlx250-tx for Renal Cancer

THOMSON REUTERS
·
Jul 21

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.
·
Jul 20

3 Australian Growth Stocks Where Insider Ownership Signals Stronger Conviction

Simply Wall St.
·
Jul 17

Telix Pharmaceuticals Completes Phase Three Enrollment for Prostate Cancer Imaging Study in Japan

MT Newswires Live
·
Jul 17

Telix Pharmaceuticals Opens Radiopharmaceutical Research, Manufacturing, Treatment Facility in Melbourne

MT Newswires Live
·
Jul 16

3 ASX Growth Stocks Backed By Insiders That Could Reward Patient Investors

Simply Wall St.
·
Jul 16